Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study
by
, , , , and
Edda Cava
1,†
,
Daniele Spadaccini
2,†,
Gianluca Aimaretti
2,3
,
Paolo Marzullo
2,3,
Beatrice Cavigiolo
3,
Deborah Farinelli
4,
Alessandra Gennari
5,
Chiara Saggia
5,
Maria Grazia Carbonelli
1,
Sergio Riso
4 and
Flavia Prodam
2,3,* 1
Unit of Dietetic and Clinical Nutrition, San Camillo-Forlanini Hospital, 00149 Rome, Italy
2
Department of Health Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy
3
SCDU Endocrinology, University Hospital “Maggiore della Carità”, Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy
4
Unit of Dietetic and Clinical Nutrition, University Hospital “Maggiore della Carità”, 28100 Novara, Italy
5
Division of Oncology, University Hospital “Maggiore della Carità”, Department of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2023, 15(17), 4401; https://doi.org/10.3390/cancers15174401
Submission received: 5 July 2023
/
Revised: 24 August 2023
/
Accepted: 31 August 2023
/
Published: 2 September 2023
(This article belongs to the Special Issue Cancer and Diabetes: What Connections Lie between Them?)
Simple Summary
Overweight and obesity are the second preventable cause of cancer, increasing the risk of its recurrence and poor outcomes, especially for breast cancer. When obesity is treated with a lifestyle intervention, breast cancer survivors may show different outcomes than the general female population, and specific causes of dropout need to be further investigated. This retrospective study aimed to investigate whether a Mediterranean diet contributed to weight management in BCS. The secondary aim was the identification of biological or anthropometrical predictors of dropout in this sample. We displayed that overweight or obese BCSs treated with a hypocaloric Mediterranean diet that concluded the 12-month follow-up period (34% of 182 women) significantly lost weight and improved their lipid profile. Moreover, lower age and higher diastolic blood pressure at baseline were found as significant predictors of dropout at 12 months. Understanding these predictors could help clinicians identify individuals who may be at a higher risk of discontinuing the intervention and design tailored strategies to support their adherence and engagement.
Abstract
Background: Reducing obesity and weight gain, which often occurs during breast cancer treatment, may represent an efficient secondary or tertiary prevention against cancer. Purpose: This retrospective observational cohort study aimed to assess the impact of a Mediterranean diet on weight and anthropometric changes in women completing active breast cancer treatment. Additionally, we sought to identify factors associated with study dropout within one year. Methods: A total of 182 female patients (20 normal weight, 59 overweight, 103 obese) received personalized Mediterranean diet interventions and underwent monthly outpatient visits. Results: Dropout rates were 42.3% at 6 months and 64.1% at 12 months. Among the obese subgroup, BMI (p < 0.001) and fat mass (p < 0.05) decreased after 6 months. At 12 months, the obese subgroup showed a borderline significant further reduction in BMI (p = 0.062). BMI or weight loss did not predict dropout at any time point. However, age (OR = 0.91) and diastolic blood pressure (OR = 1.07) were significant predictors of dropout at 12 months. Conclusion: Implementing a Mediterranean diet can lead to weight and anthropometric improvements in breast cancer survivors. Further research is necessary to explore the long-term effects of weight loss on these individuals, identify effective dietary approaches, and consider specific predictors of dropout.
